OBJECTIVE: Rheumatoid arthritis (RA) is a systemic autoimmune disease that often leads to joint damage. The mechanisms of bone damage in RA are complex, involving activation of bone-resorbing osteoclasts (OCs) by synoviocytes and Th17 cells. This study was undertaken to investigate whether B cells play a direct role in osteoclastogenesis through the production of RANKL, the essential cytokine for OC development. METHODS: RANKL production by total B cells or sorted B cell subpopulations in the peripheral blood and synovial tissue from healthy donors or anti-cyclic citrullinated peptide-positive patients with RA was examined by flow cytometry, real-time polymerase chain reaction, enzyme-linked immunosorbent assay, and immunohistochemical analysis. To define direct effects on osteoclastogenesis, B cells were cocultured with CD14+ monocytes, and OCs were enumerated by tartrate-resistant acid phosphatase staining. RESULTS: Healthy donor peripheral blood B cells were capable of expressing RANKL upon stimulation, with switched memory B cells (CD27+IgD-) having the highest propensity for RANKL production. Notably, switched memory B cells in the peripheral blood from RA patients expressed significantly more RANKL compared to healthy controls. In RA synovial fluid and tissue, memory B cells were enriched and spontaneously expressed RANKL, with some of these cells visualized adjacent to RANK+ OC precursors. Critically, B cells supported OC differentiation in vitro in a RANKL-dependent manner, and the number of OCs was higher in cultures with RA B cells than in those derived from healthy controls. CONCLUSION: These findings reveal the critical importance of B cells in bone homeostasis and their likely contribution to joint destruction in RA.
OBJECTIVE:Rheumatoid arthritis (RA) is a systemic autoimmune disease that often leads to joint damage. The mechanisms of bone damage in RA are complex, involving activation of bone-resorbing osteoclasts (OCs) by synoviocytes and Th17 cells. This study was undertaken to investigate whether B cells play a direct role in osteoclastogenesis through the production of RANKL, the essential cytokine for OC development. METHODS:RANKL production by total B cells or sorted B cell subpopulations in the peripheral blood and synovial tissue from healthy donors or anti-cyclic citrullinated peptide-positive patients with RA was examined by flow cytometry, real-time polymerase chain reaction, enzyme-linked immunosorbent assay, and immunohistochemical analysis. To define direct effects on osteoclastogenesis, B cells were cocultured with CD14+ monocytes, and OCs were enumerated by tartrate-resistant acid phosphatase staining. RESULTS: Healthy donor peripheral blood B cells were capable of expressing RANKL upon stimulation, with switched memory B cells (CD27+IgD-) having the highest propensity for RANKL production. Notably, switched memory B cells in the peripheral blood from RApatients expressed significantly more RANKL compared to healthy controls. In RA synovial fluid and tissue, memory B cells were enriched and spontaneously expressed RANKL, with some of these cells visualized adjacent to RANK+ OC precursors. Critically, B cells supported OC differentiation in vitro in a RANKL-dependent manner, and the number of OCs was higher in cultures with RA B cells than in those derived from healthy controls. CONCLUSION: These findings reveal the critical importance of B cells in bone homeostasis and their likely contribution to joint destruction in RA.
Authors: Ya-Hui Chiu; Kofi A Mensah; Edward M Schwarz; Yawen Ju; Masahiko Takahata; Changyong Feng; Loralee A McMahon; David G Hicks; Ben Panepento; Peter C Keng; Christopher T Ritchlin Journal: J Bone Miner Res Date: 2012-01 Impact factor: 6.741
Authors: Allen Anandarajah; Ralf Thiele; Ellen Giampoli; Johnny Monu; Gwy-Suk Seo; Changyong Feng; Christopher T Ritchlin Journal: J Rheumatol Date: 2014-10-01 Impact factor: 4.666
Authors: Pablo Engel; José A Gómez-Puerta; Manuel Ramos-Casals; Francisco Lozano; Xavier Bosch Journal: Pharmacol Rev Date: 2011-01-18 Impact factor: 25.468
Authors: N Dalbeth; T Smith; S Gray; A Doyle; P Antill; M Lobo; E Robinson; A King; J Cornish; G Shalley; A Gao; F M McQueen Journal: Ann Rheum Dis Date: 2008-09-02 Impact factor: 19.103
Authors: Lorraine Yeo; Kai-Michael Toellner; Mike Salmon; Andrew Filer; Christopher D Buckley; Karim Raza; Dagmar Scheel-Toellner Journal: Ann Rheum Dis Date: 2011-07-08 Impact factor: 19.103
Authors: Diana G Adlowitz; Jennifer Barnard; Jamie N Biear; Christopher Cistrone; Teresa Owen; Wensheng Wang; Arumugam Palanichamy; Ezinma Ezealah; Debbie Campbell; Chungwen Wei; R John Looney; Inaki Sanz; Jennifer H Anolik Journal: PLoS One Date: 2015-06-05 Impact factor: 3.240
Authors: Yahui Grace Chiu; Tianmeng Shao; Changyong Feng; Kofi A Mensah; Michael Thullen; Edward M Schwarz; Christopher T Ritchlin Journal: Arthritis Res Ther Date: 2010-01-26 Impact factor: 5.156
Authors: Kofi A Mensah; Jeff W Chen; Jean-Nicolas Schickel; Isabelle Isnardi; Natsuko Yamakawa; Andrea Vega-Loza; Jennifer H Anolik; Richard A Gatti; Erwin W Gelfand; Ruth R Montgomery; Mark C Horowitz; Joe E Craft; Eric Meffre Journal: Sci Transl Med Date: 2019-11-20 Impact factor: 17.956